Latest: FDA Approves New Biosimilar for Oncology Treatment
Oncology

Chemoradiation Shows Long-Term Clinical Benefit in High-Risk Gastric Cancer

by Cancer Network
0 Comments
0 Mins
The incidence of grade 3 to 4 acute toxicities was similar in patients with high-risk gastric cancer treated with chemoradiation or chemotherapy.
Tags:
Cancer Network
Author

Cancer Network

Previous Post
Chemotherapy Confers No Survival Benefit in Older Breast Cancer Population
Next Post
STAT+: Trump administration restored funding for major diabetes study. The pause still set researchers back
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago